SunRegen ^None

SunRegen is a biopharmaceutical company that develops drugs to treat neurodegenerative diseases, with a focus on innovative treatments for neurological, neuromuscular, and ophthalmic diseases. Their first product candidates target primary optical atrophy and are being evaluated for use in serious neurological/neuromuscular diseases such as ALS, Huntington's, Alzheimer\u2019s, and Parkinson\u2019s disease. The company is composed of passionate and experienced founders and experts in drug development and clinical research. SunRegen is determined to bring life-changing treatments to patients with unmet medical needs.